Actinogen Medical Limited (ASX:ACW)
Australia · Delayed Price · Currency is AUD 0.0260
+0.0010 (4.00%)
Jul 29, 2025, 4:10 PM AEST
Actinogen Medical Market Cap
Actinogen Medical has a market cap or net worth of 82.61 million as of July 29, 2025. Its market cap has decreased by -58.57% in one year.
Market Cap
82.61M
Enterprise Value
60.03M
Revenue
9.02M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.03
Market Cap Chart
Since October 16, 2007, Actinogen Medical's market cap has increased from 12.97M to 82.61M, an increase of 536.78%. That is a compound annual growth rate of 10.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 28, 2025 | 79.43M | 1.42% |
| Dec 31, 2024 | 78.32M | 54.29% |
| Dec 29, 2023 | 50.76M | -71.90% |
| Dec 30, 2022 | 180.63M | -36.39% |
| Dec 31, 2021 | 283.98M | 832.13% |
| Dec 31, 2020 | 30.47M | -24.18% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 131.71B |
| Pro Medicus | 33.76B |
| Cochlear | 20.89B |
| Sonic Healthcare | 13.93B |
| Ramsay Health Care | 8.92B |
| Telix Pharmaceuticals | 6.95B |
| Ansell | 4.40B |
| Mesoblast | 3.19B |